These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24682291)

  • 21. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
    Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
    ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Ng KT; Yap JLL
    Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study).
    Paterna S; Fasullo S; Parrinello G; Cannizzaro S; Basile I; Vitrano G; Terrazzino G; Maringhini G; Ganci F; Scalzo S; Sarullo FM; Cice G; Di Pasquale P
    Am J Med Sci; 2011 Jul; 342(1):27-37. PubMed ID: 21701268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant.
    Shiraishi M; Murakami T; Nawa T; Kobayashi H; Nagamine H; Shiraga K; Higashi K; Nakajima H
    Int J Cardiol; 2016 Jul; 215():127-8. PubMed ID: 27111174
    [No Abstract]   [Full Text] [Related]  

  • 25. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure.
    Parrinello G; Paterna S; Di Pasquale P; Torres D; Mezzero M; Cardillo M; Fasullo S; La Rocca G; Licata G
    J Card Fail; 2011 Apr; 17(4):331-9. PubMed ID: 21440872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
    Niu X; Yang C; Yao Y
    Int J Cardiol; 2014 Sep; 176(1):288. PubMed ID: 25042652
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply: Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
    Gandhi S; Mosleh W; Myers RB
    Int J Cardiol; 2014 Oct; 176(3):1153. PubMed ID: 25125011
    [No Abstract]   [Full Text] [Related]  

  • 29. Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
    Wu MY; Chang NC; Su CL; Hsu YH; Chen TW; Lin YF; Wu CH; Tam KW
    J Crit Care; 2014 Feb; 29(1):2-9. PubMed ID: 24331943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
    Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
    Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
    Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
    Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure.
    Lafrenière G; Béliveau P; Bégin JY; Simonyan D; Côté S; Gaudreault V; Israeli Z; Lavi S; Bagur R
    World J Cardiol; 2017 Aug; 9(8):685-692. PubMed ID: 28932357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
    Issa VS; Bacal F; Mangini S; Carneiro RM; Azevedo CH; Chizzola PR; Ferreira SM; Bocchi EA
    Arq Bras Cardiol; 2007 Oct; 89(4):251-5. PubMed ID: 17992382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
    Licata G; Tuttolomondo A; Licata A; Parrinello G; Di Raimondo D; Di Sciacca R; Cammà C; Craxì A; Paterna S; Pinto A
    Aliment Pharmacol Ther; 2009 Aug; 30(3):227-35. PubMed ID: 19438847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.
    Tuttolomondo A; Pinto A; Parrinello G; Licata G
    Semin Nephrol; 2011 Nov; 31(6):513-22. PubMed ID: 22099508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
    Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
    Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renoprotective effect of small volumes of hypertonic saline solution in chronic heart failure patients with marked fluid retention: results of a case-control study].
    De Vecchis R; Ciccarelli A; Ariano C; Pucciarelli A; Cioppa C; Giasi A; Fusco A; Cantatrione S
    Herz; 2011 Feb; 36(1):12-7. PubMed ID: 20978728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
    De Vecchis R; Ciccarelli A; Pucciarelli A
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.
    Tuttolomondo A; Pinto A; Di Raimondo D; Corrao S; Di Sciacca R; Scaglione R; Caruso C; Licata G
    Nutr Metab Cardiovasc Dis; 2011 May; 21(5):372-9. PubMed ID: 20346637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.